Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future
It has been seventy years since a water-soluble version of vitamin E called tocophersolan (also known as TPGS) was produced; it was approved by USFDA in 1998 as an inactive ingredient. Drug formulation developers were initially intrigued by its surfactant qualities, and gradually it made its way int...
Main Authors: | Abhishesh Kumar Mehata, Aseem Setia, Vikas, Ankit Kumar Malik, Rym Hassani, Hamad Ghaleb Dailah, Hassan A. Alhazmi, Ahmed A. Albarraq, Syam Mohan, Madaswamy S. Muthu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/3/722 |
Similar Items
-
Editorial: Women in nanomedicine
by: Lay-Hong Chuah, et al.
Published: (2023-01-01) -
Nanotheranostics Targeting the Tumor Microenvironment
by: Catarina Roma-Rodrigues, et al.
Published: (2019-08-01) -
Industrialization’s eye view on theranostic nanomedicine
by: Maharajan Sivasubramanian, et al.
Published: (2022-08-01) -
Cancer Nanotheranostics
by: Kamolrat Thanapprapasr
Published: (2014-10-01) -
Application of molecular dynamics simulation in self-assembled cancer nanomedicine
by: Xueli Xu, et al.
Published: (2023-05-01)